Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Derman

Orthopaedic Surgery of the Spine Frisco, TX Medical Doctor

NPI 1942567961 CMS profile 4220758

5858 Main St Ste 120, Frisco, TX 75033

Open in the dashboard

General payments

$785,363

556 records reported · program years 2019–2025

Research payments

$21,375

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Peter Derman of Frisco, TX is reported in the CMS Open Payments database as having received $785,363 across 556 general payments and $21,375 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $439,095 278
2024 General $141,977 132
2023 General $81,758 49
2022 General $55,932 29
2021 General $43,464 30
2020 General $16,870 9
2020 Research $21,375 1
2019 General $6,267 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Derman
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Peter Derman were reported at $439,095. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Peter Derman Orthopaedic Surgery of the Spine median Middle half National median
2019 $6,267 $2,106 $337–$18,608 $163
2020 $16,870 $1,213 $156–$15,082 $114
2021 $43,464 $1,834 $271–$15,617 $132
2022 $55,932 $2,015 $320–$17,036 $149
2023 $81,758 $1,925 $336–$14,599 $160
2024 $141,977 $2,110 $341–$12,483 $164
2025 $439,095 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $528,019 337 payments
  2. Joimax, Inc. $121,323 17 payments
  3. DeGen Medical, Inc. $47,030 35 payments
  4. Integrity Implants Inc. $37,475 8 payments
  5. Integrity Implants Inc $21,071 24 payments
  6. Synthes GmbH $16,971 17 payments
  7. Neo Spine USA Inc $4,016 2 payments
  8. NuVasive, Inc. $1,850 22 payments
  9. Globus Medical, Inc. $1,668 15 payments
  10. Pylant Medical $1,463 18 payments
  11. Other $4,477 61 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $438,059 55 payments
  2. Consulting Fee $181,833 53 payments
  3. Travel and Lodging $93,256 191 payments
  4. Royalty or License $49,927 14 payments
  5. Food and Beverage $13,751 229 payments
  6. Honoraria $8,254 9 payments
  7. Entertainment $283 5 payments
Products named General payments · program years 2019–2025
  1. FlareHawk $41,924 23 payments
  2. ALIF Lumbar Interbody System $13,616 6 payments
  3. Solar $12,544 6 payments
  4. ALIF Lumbar Interbody $10,687 7 payments
  5. Cervical Stand Alone $9,598 5 payments
  6. XR $6,482 3 payments
  7. Neo Pedicle Screw System $4,016 2 payments
  8. XLIF $879 8 payments
  9. ExcelsiusGPS Robotic Navigation System $752 7 payments
  10. ReActiv8 $588 7 payments
  11. Other $5,551 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Orthofix Medical, Inc. $21,375 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

176

Median for Orthopedic Surgery: 203

Drug cost

$1,629

Median for Orthopedic Surgery: $1,433

Branded share of claims

8%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 84 $772
Cyclobenzaprine Hcl Generic 32 $390
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 14 $245
Methylprednisolone Generic 35 $202
Meloxicam Generic 11 $19

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$150,005

Medicare's payments for the services billed

Medicare patients

311

Average age 73

Services billed

903

149 women, 162 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 30%
Diabetes 24%
Depression 23%
Chronic kidney disease 22%
Cancer 17%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

557 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record